Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 160

1.

Hypermetabolic lesions of the pancreas on FDG PET/CT.

Dong A, Dong H, Zhang L, Zuo C.

Clin Nucl Med. 2013 Sep;38(9):e354-66. doi: 10.1097/RLU.0b013e3182708503.

PMID:
23486316
[PubMed - indexed for MEDLINE]
2.

Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.

Santhosh S, Mittal BR, Bhasin D, Srinivasan R, Rana S, Das A, Nada R, Bhattacharya A, Gupta R, Kapoor R.

J Gastroenterol Hepatol. 2013 Feb;28(2):255-61. doi: 10.1111/jgh.12068.

PMID:
23278193
[PubMed - indexed for MEDLINE]
3.

A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.

Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT.

Ann Surg. 2009 Dec;250(6):957-63. doi: 10.1097/SLA.0b013e3181b2fafa.

PMID:
19687736
[PubMed - indexed for MEDLINE]
4.

The usefulness of (18)F-FDG PET/MRI fusion image in diagnosing pancreatic tumor: comparison with (18)F-FDG PET/CT.

Nagamachi S, Nishii R, Wakamatsu H, Mizutani Y, Kiyohara S, Fujita S, Futami S, Sakae T, Furukoji E, Tamura S, Arita H, Chijiiwa K, Kawai K.

Ann Nucl Med. 2013 Jul;27(6):554-63. doi: 10.1007/s12149-013-0719-3. Epub 2013 Apr 12.

PMID:
23580090
[PubMed - indexed for MEDLINE]
5.

Utility of 18F-FDG PET/CT for differentiation of autoimmune pancreatitis with atypical pancreatic imaging findings from pancreatic cancer.

Lee TY, Kim MH, Park do H, Seo DW, Lee SK, Kim JS, Lee KT.

AJR Am J Roentgenol. 2009 Aug;193(2):343-8. doi: 10.2214/AJR.08.2297.

PMID:
19620430
[PubMed - indexed for MEDLINE]
6.

Value of 18-fluorodeoxyglucose positron emission tomography in the management of patients with cystic tumors of the pancreas.

Sperti C, Pasquali C, Chierichetti F, Liessi G, Ferlin G, Pedrazzoli S.

Ann Surg. 2001 Nov;234(5):675-80.

PMID:
11685032
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

¹⁸F-FDG PET/CT imaging of the pancreas: spectrum of diseases.

Nguyen VX, Nguyen CC, Nguyen BD.

JOP. 2011 Nov 9;12(6):557-66. Review.

PMID:
22072244
[PubMed - indexed for MEDLINE]
Free Article
8.

FDG PET/CT findings of solid pseudopapillary tumor of the pancreas with CT and MRI correlation.

Dong A, Wang Y, Dong H, Zhang J, Cheng C, Zuo C.

Clin Nucl Med. 2013 Mar;38(3):e118-24. doi: 10.1097/RLU.0b013e318270868a.

PMID:
23354028
[PubMed - indexed for MEDLINE]
10.

The possible role of F-18 FDG positron emission tomography in the differential diagnosis of focal pancreatic lesions.

Papós M, Takács T, Trón L, Farkas G, Ambrus E, Szakáll S Jr, Lonovics J, Csernay L, Pávics L.

Clin Nucl Med. 2002 Mar;27(3):197-201.

PMID:
11852308
[PubMed - indexed for MEDLINE]
11.

Diagnostic usefulness of FDG PET for pancreatic mass lesions.

Koyama K, Okamura T, Kawabe J, Nakata B, Chung KH, Ochi H, Yamada R.

Ann Nucl Med. 2001 Jun;15(3):217-24.

PMID:
11545191
[PubMed - indexed for MEDLINE]
12.

F-18-fluorodeoxyglucose positron emission tomography in differentiating malignant from benign pancreatic cysts: a prospective study.

Sperti C, Pasquali C, Decet G, Chierichetti F, Liessi G, Pedrazzoli S.

J Gastrointest Surg. 2005 Jan;9(1):22-8; discussion 28-9.

PMID:
15623441
[PubMed - indexed for MEDLINE]
13.

Hyperaccumulation of (18)F-FDG in order to differentiate solid pseudopapillary tumors from adenocarcinomas and from neuroendocrine pancreatic tumors and review of the literature.

Guan ZW, Xu BX, Wang RM, Sun L, Tian JH.

Hell J Nucl Med. 2013 May-Aug;16(2):97-102. doi: 10.1967/s002449910084. Epub 2013 May 20. Review.

PMID:
23687644
[PubMed - indexed for MEDLINE]
Free Article
14.

18F-FDG PET/CT findings in patients with Kikuchi disease.

Kong E, Chun K, Hong Y, Hah J, Cho I.

Nuklearmedizin. 2013;52(3):101-6. doi: 10.3413/Nukmed-0513-12-06. Epub 2013 Mar 27.

PMID:
23681151
[PubMed - indexed for MEDLINE]
15.

18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.

Sperti C, Bissoli S, Pasquali C, Frison L, Liessi G, Chierichetti F, Pedrazzoli S.

Ann Surg. 2007 Dec;246(6):932-7; discussion 937-9.

PMID:
18043094
[PubMed - indexed for MEDLINE]
16.

Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma.

Delbeke D, Rose DM, Chapman WC, Pinson CW, Wright JK, Beauchamp RD, Shyr Y, Leach SD.

J Nucl Med. 1999 Nov;40(11):1784-91.

PMID:
10565771
[PubMed - indexed for MEDLINE]
Free Article
17.

Diagnostic impact of 18F-FDG PET-CT evaluating solid pancreatic lesions versus endosonography, endoscopic retrograde cholangio-pancreatography with intraductal ultrasonography and abdominal ultrasound.

Schick V, Franzius C, Beyna T, Oei ML, Schnekenburger J, Weckesser M, Domschke W, Schober O, Heindel W, Pohle T, Juergens KU.

Eur J Nucl Med Mol Imaging. 2008 Oct;35(10):1775-85. doi: 10.1007/s00259-008-0818-x. Epub 2008 May 15.

PMID:
18481063
[PubMed - indexed for MEDLINE]
18.

Cutaneous and subcutaneous imaging on FDG-PET: benign and malignant findings.

Blumer SL, Scalcione LR, Ring BN, Johnson R, Motroni B, Katz DS, Yung EY.

Clin Nucl Med. 2009 Oct;34(10):675-83. doi: 10.1097/RLU.0b013e3181b53845.

PMID:
19893399
[PubMed - indexed for MEDLINE]
19.

In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy.

Berthet L, Cochet A, Kanoun S, Berriolo-Riedinger A, Humbert O, Toubeau M, Dygai-Cochet I, Legouge C, Casasnovas O, Brunotte F.

J Nucl Med. 2013 Aug;54(8):1244-50. doi: 10.2967/jnumed.112.114710. Epub 2013 May 14.

PMID:
23674577
[PubMed - indexed for MEDLINE]
Free Article
20.

Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization.

Choi JY, Lee KS, Kim HJ, Shim YM, Kwon OJ, Park K, Baek CH, Chung JH, Lee KH, Kim BT.

J Nucl Med. 2006 Apr;47(4):609-15.

PMID:
16595494
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk